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Abstract
It is well known that the implantation of electrodes for deep brain stimulation ormicroelectrode
probes for the recording of neuronal activity is always accompanied by the response of the brain’s
immune system leading to the formation of a glial scar around the implantation sites. The implanta-
tion of electrodes causesmassive release of adenosine-5′-triphosphate (ATP) and different cytokines
into the extracellular space and activates themicroglia. The releasedATP and the products of its
hydrolysis, such asADP and adenosine, become themain elementsmediating chemotactic sensitivity
andmotility ofmicroglial cells via subsequent activation of P2Y2,12 as well as A3A/A2A adenosine
receptors. The size and density of an insulating sheath around the electrode, formed bymicroglial
cells, are important criteria for the optimization of the signal-to-noise ratio duringmicroelectrode
recordings or parameters of electrical current delivered to the brain tissue.Here, we study a purinergic
signaling pathway underlying the chemotacticmotion ofmicroglia towards implanted electrodes as
well as the possible impact of an anti-inflammatory coating consisting of the interleukin-1 receptor
antagonist.We present amodel describing the formation of a stable aggregate around the electrode
due to the joint chemo-attractive action of ATP andADP and themixed influence of extracellular
adenosine. The bioactive coating ismodeled as a source of chemo-repellent located near the electrode
surface. The obtained analytical and numerical results allowed us to reveal the dependences of size and
spatial location of the insulating sheath on the amount of releasedATP and estimate the impact of
immune suppressive coating on the scarring process.
1. Introduction
Nowadays, implantation of electrodes for deep brain recording of neuronal signals and electrical deep brain
stimulation (DBS) are widely used for the therapy of several neurologic disorders [2–4, 1]. In addition,
increasing evidence suggests that implantable electrode technology, includingmultielectrode arrays (MEA),
may be applied in the context of brain–machine interface [5–7].However, recent studies reported a decrease in
the quality of neuronal signals and the number of functional electrodes in chronicMEA recordings caused by the
brain’s immune response [8, 9]. The in vivo response to the implantation of an electrode can be divided into the
initial acute response to the cell damage and chronic response resulting in a formation of the electrode–tissue
interface around the implantation site [8, 10]. Several clinically usedDBS devices use voltage-controlled
stimulation, which leads to a strong dependence of the injected current on the impedance of the electrode–tissue
interface, which separates electrodes from the surrounding brain tissue [14, 16]. The impedance of the layer
forming this interface increases with time, which in some casesmakes it necessary to substantially increase the
amplitude and/or frequency of the stimulation signal [18]. As follows from the immunohistochemical analysis,
themain cellular components of the electrode–tissue interface are themicroglial cells and reactive astrocytes [9].
Microglia are clustered around the implant in a reactive tissue sheath and persist throughout thewhole lifetime
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of the implant [10, 11]. The reactive astrocytes surround this inner core ofmicroglia in an encapsulation layer
referred to as the glial scar [8–10]. Thus, the glial scar encapsulates the electrode, creating a physical barrier
between the electrode and the neurons that, in turn, defines a time limit for chronic recordings and stimulation
[9, 1]. The results of in vitro and in vivo impedance spectroscopy togetherwith the results of recent theoretical
studies have shown that the resistivity of the encapsulation tissue is sufficient to alter the shape andmagnitude of
the electricfield generated by chronically implanted electrodes [12, 15, 16, 21, 22].
Themechanism of the glial scar development is still not completely understood. Recent in vitro studies have
shown that implanted electrodes cause chronic, local inflammation that is correlatedwith local
neurodegeneration [13]. Indeed, the electrode’s implantation initiates immune response, which is accompanied
by amassive release of ATP and different immune response regulation factors such as tumor growth factor and
pro-inflammatory cytokines [19, 20]. The strength of the immune response is tightly related to the level of
extracellular ATP, as clearly demonstrated via the reduction of the inflammatory response bymeans of an
inhibition of the P2X(7) receptor [23], which is the key player in processing and release of pro-inflammatory
cytokines, such as interleukin (IL)-1 [24].Moreover, ATP plays the role of a chemo-attractant, providing a clear
‘navigation signal’ formacrophages [25]. The implantation of electrodes aswell as electrical stimulation induce a
massive release of ATP from the injured cells [26], thus initiating a chemotactic response ofmicroglia, which
move towards the electrodes along the gradient of ATP concentration [25, 28, 29]. The formation of a glial scar
around the electrode is a long-termprocess [8, 10], which is accompanied by the release of ATP and pro-
inflammatory cytokines like IL-1 [20] aswell as others gliotransmitters [30–32]. Some of the recently proposed
strategies for improving the brain–electrode interface utilize the so-called ‘passive’ coating of electrodes by
laminin [47, 48] aswell as the anti-inflammatory coating by proteins of the IL-1 receptor antagonist (IL-1 ra)
[49]. The nanoscale laminin coating has a stimulatory effect on earlymicroglia activation andmight potentially
improve chronic neural recordings through the dispersion of the glial scar [48]. Themain goal of the strategy
utilizing the bioactive coating by proteins of IL-1 ra is toweaken the immune response and limit the area around
electrodewhere the scarring processes are observed [49].
Recent experimental studies ofmicroglia chemotaxis revealed the crucial role of purinergic receptors and
ectonucleotidase cd39/ENTPDase1 and ecto-5′-nucleotidase/cd73 that degrade nucleotides to nucleosides,
including adenosine [35]. In particular, ADP, AMP and adenosine, being products of ATPhydrolysis, play
contrasting roles in the chemotactic signaling ofmicroglia [25, 27, 29]. The extracellular ATP andADP activate
the purinergic P2X4 andGi-coupled P2Y2,12 receptors and act as chemo-attractants [33, 36], whereas adenosine,
initially functioning in concert with P2Y2,12 via an activation ofGi-coupled A3A receptors, later on acts as a
chemo-repellent via the stimulation of adenosineGs-coupledA2A receptors what causes retractions ofmicroglia
[34, 37]. Thus, the co-stimulation of purinergic and adenosine receptors is the requirement for themicroglia
migration and expression of cd39 and cd73 to control theATP/adenosine balance [27, 35, 37, 38]. Themain
reaction steps forming the autocrine purinergic feedback loop are schematically presented infigure 1.
Apparently, to explore themechanismof acute response and glial scarring one has tomodel the chemotactic
motion ofmicroglia towards the electrode, which ismantained by the autocrine purinergic feedback and results
in the formation of the ‘front line’ consisting of themicroglia cells due glued to the electrode’s surface [9]. To
model the impact of bioactive coating on the scarring process, one has to additionally incorporate a source of IL-
1 ra into themodel.
Thefirst andmost famous continuousmathematicalmodel for chemotaxis was proposedmore than forty
years ago byKeller and Segel [39]. Since then, theKeller–Segelmodel has become one of the standardmodels in
mathematical biology and is often used in situations when a simple continuousmacroscopicmodel of an
aggregation process is required, which also takes into account some features of themicroscopic dynamics [40].
Numerousmodifications of the classical Keller–Segelmodel were developed to take into account important
features of real systems, such as receptors’ dynamics and the effect of cells’ overcrowding [40, 41]. The
computationalmodeling of chemotactic signaling andmotility ofmacrophages is of particular interest due to
the important role they play in the inflammatory response [42]. Themathematicalmodels of acute
inflammatory processes usually describe the chemotactic response ofmacrophages to pro- and anti-
inflammatory cytokines released by these cells [43, 44].However, there is growing evidence for the key role
played byATP and the products of its hydrolysis in the extracellular space (ECS) [27, 33, 35, 45].Moreover, it
was observed that deletion of cd39 leads to a drastic decrease of the accumulation ofmicroglia [35], underlying
the crucial role of autocrine purinergic feedback loops formacrophage chemotaxis [25]. Apparently, the role of
ATP aswell as products of its degradation in the immune response duringDBS is of special interest and
importance because of themassive release of ATPduring electrode implantation and electrical stimulation [26].
The objective of the present study is tomodel the chemotactic signaling and the aggregation ofmicroglia in
the presence of the stationary gradients of ATP, ADP and adenosine during the acute response caused by an
electrode implantation.We present a simple continuousKeller–Segel basedmodel, which describes dynamics of
themicroglia cells density and allows us to estimate the dependences of size and location of the insulating sheath
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on the amount of ATP released into the ECS. Apart from that, the impact of bioactive coating consisting of the
IL-1 ra proteins on the glial scarring process is also taken into account in ourmodel. Themodel of the glial
scarring process is introduced in section 2. The analytical results for the linearized dimensionless equations are
presented in section 3. In section 4, we analyzed the impact of the anti-inflammatory bioactive coating bymeans
of stability theory. The results of numerical simulations for the two-dimensional case are presented in section 5.
Our conclusions are given in section 6.
2.Model ofmicroglial chemotactic acute response
The proposedmacroscopicmodel ofmicroglia chemotaxis is governed by the following equations:
    
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where n is themicroglia density, y1,2,3,4 are the concentrations of ATP, ADP, AMP and adenosine, respectively.
D1,2,3,4,5 are the diffusion coefficients and χ1,2,3,4 are the chemotacticmotility coefficients.We assume that the
Figure 1. Schematic picture illustrating themain stages of the autocrine purinergic feedback loop involved in chemotaxis ofmicroglia.
At thefirst stage, ATP released from the damaged cells (green filled circles) activates P2X4,7 receptors and evokes anATP-induced
release of ATP frommicroglial cells [51] and thus results in an activation of P2Y2,12 receptors, which provides signal amplification and
facilitates the sensing of the shadow chemotactic gradients [27]. The second stage is characterized by the polarization of the cells
within the chemotactic gradient field and autocrine activation of A3A receptors by adenosine formed fromAMPby ecto-5′-
nucleotidase (CD73). At the last stage, adenosine (red filled circules) activates A2A receptors which causes retraction of themicroglial
cells and theirmovement towards the gradient of ATP.
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chemotactic sensitivity ofmicroglia to the ATP andADP is concentration-dependent and is limited by the
saturation of the binding process. The saturation of purinergic receptors is described by nonlinear interaction
terms in thefirst equation and prevents the blow-up of a solution, which is observed in the classical Keller–Segel
model [58]. The chain of kinetic equations describing the process of hydrolysis →y yATP( ) ADP( )1 2
→ →y yAMP( ) adenosine( )3 5 in the ECS [50] is padded by the equation for the concentration of IL-1 ra proteins
y5. Here, themaximal rates of the enzymatic reactions are v1,2,3,4, w1, and k1,2,3,4, ki are the corresponding
Michaelis–Menten constants. Themaximal rate of ATP release bymicroglia is a.We use the simplifying
assumption that amount of ATP released by themicroglial cells is linearly proportional to the number of cells.
Another additional source of ATP is the ATP-inducedATP release by reactive astrocytes whosemaximal rate
equals b [42]. The nonlinear functionθ y( )4 modulating sensitivity ofmicroglia to adenosine is defined as the
θ β γ= − +y y q y( ) ( ) ( )s4 4
2
ado 4
2 . The specific formof the θ-functionwas chosen in such away to take into
account the interaction between adenosine andA3A/A2A receptors [27, 34, 54]. In particular, as can be seen
from figure 2(a), the nonlinear θ-function takes positive values atmoderate concentrations of adenosine in ECS,
whichmeans the enhancement of chemotaxis via activation of the adenosine A3A receptors, whereas rather high
levels of adenosine cause an activation of A2A receptors which, in turn, leads to substantial retractions of
microglial cells and their directedmotion towards the electrode. The last equation of the system (1) describes the
diffusion of IL-1 ra y5, which spreads away from the coated electrode surface and limits the amount ofmicroglia
aggregated around the implantation site. Apparently, the extent towhich the IL-1 ra spreads in the ECS depends
on the rate of its persistent emission L0 and rate of interaction betweenmicroglia cells and IL-1 ra proteins d.
3. Analytical results for the linearized equations
Let us assume that the total number ofmicroglial cells is fixed and consider the one-dimensional case with no-
flux boundary conditions:
Figure 2. (a) The graphical representation of theθ y( )4 function, which allows us to incorporate the different impact of adenosine on
the A3A/A2A receptors for γ = 0.15 and β = 5 intomodel (1); (b) the stationary distributions of ATP and its hydrolysis products
together with the stationary distribution of IL-1 antagonist (8). It is assumed that the electrode is located at x=0; (c) the stationary
distributions ofmicroglial cells’ densities (13), calculated for the different values of chemosensitivity to IL-1 ra χ4 and corresponding
spatial dependences of the total gradient (10). The points of zero-crossing xmax (blackfilled circles) and globalminima xb (blue filled
circles) for the grad(x) define the location and size of an aggregate. Themaximumvalue of density inside the aggregate is labeled as
nmax. The values of the other parameters used in the calculationsmay be found in table 1.
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where it is assumed that the electrode is placed at x=0 and L is afinite interval or half-plane.We chose
asymmetric boundary conditions for the ATP concentration: = ∞ =y t J y t(0, ) , ( , ) 01 0 1 , where J0 is the
constant concentration of ATP,which ismaintained by the persistent ATP release frommicroglia and astrocytes
at the closest proximity to the electrode surface. Also, it is assumed that the concentration of IL-1 ra near the
electrode surface ismaintained at the constant levelM0. Boundary conditions for ADP, AMP and adenosine are
assumed to be zero = ∞ =y t y t(0, ) 0, ( , ) 02,3,4 2,3,4 . The initial conditions for the cell density and
concentrations are ϵ ξ= +n x n t(0, ) ( )0 and ϵ ξ= +y x y t(0, ) ( )i i
0 , where = ∈ ∞n x0.5, [0, ]0 , andξ t( ) is
theGaussian noise of intensity ϵ.
The originalmodel (1) can be non-dimensionalized bymeans of the following scales:
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where = −nˆ 10 3 is the equilibrium cell density. The time scale is normalized on a slow rate of adenosine uptake.
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The obtained equations (5) can be linearized in the assumption that velocities of diffusivemotion near the
surfaces of the cells are the same for all chemicals ( = = = =D D D D D2 3 4 5 6) and rates of enzymatic reactions
v1,2,3,4,5 are constant and take theirmaximal values:
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The studies of the relationship between the chemical signaling and nonlocal interactions of the cells clearly
demonstrated that when the chemicals diffuse in the ECSmore rapidly than the cells ( ≪D 1n ), the quasi-
stationary spatial distributions of chemicals develop on a faster time scale [43, 55]. The lattermeans stationarity
of the spatial distributions of ATP, ADP, AMP, adenosine and IL-1 ra, which are described by the following
steady states equations:
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Linear equations (7) can be solved one by one for the boundary conditions given above in (2). In the one-
dimensional case, the quasi-stationary spatial distributions of all chemicals y1,2,3,4,5 can bewritten in the
following explicit forms:
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where = −( )J J B n B0 1 0 2 . These stationary distributions are plotted infigure 2(b).
Given the above expressions for the quasi-stationary distributions (8), the stationary distribution for the
density of themicroglial cells can be obtained from the equation:
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is the total gradient,maintaining themotion ofmicroglia towards the source of the inflammation. As follows
from the expressions (9) and (10), the density ofmicroglial cells aggregated around the electrode is described by
the following equation:
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Thefinal expression for the cell density can be obtained after integration in (11):
ζ= ( )n x x D( ) exp ( ) . (13)n
As seen from figure 2(c), the instability of the homogeneous steady state leads to the appearance of an
aggregate, the size and spatial location of which are determined by the coordinates of the globalminimumand
zero-crossing in grad(x) (10). The physicalmeaning of the zero-crossing in (10) can be easily understood as a
point where the chemoattraction along the total gradient is balanced by the density of the glial scar. As can also
be seen fromfigure 2(c), such zero-crossing points precisely correspond to the coordinates of themaximal
values of the density in the formed aggregates. At the same time, the spatial coordinate of the globalminimum in
grad(x)might be considered as the point at which the influence of the cells’ density overcomes chemoattraction
and forms the natural ‘backward border’ of the aggregate. As follows from the results presented in figure 2(c), the
usage of biologically active coat emitting IL-1 ra proteins leads to a drastic reduction of themicroglial cells
density inside the insulating sheath and shifts it away from the electrode surface. To study the impact of IL-1 ra
on themicroglia chemotaxis process, we calculated the size and absolutemaximal values of the cell density inside
the aggregate as functions of the amount of ATP, released frommicroglia and astrocytes.
As seen from figure 3(a), the spatial location of a globalminimum xb defining the aggregate boundary
strongly depends on the rate of the released ATP. Atmoderate rates of ATP release, thewidth of the insulating
sheath is increased both in the presence of bioactive coating andwhen IL-1 ra is absent. The increase of the rate
of ATP release in the absence of bioactive coating causes the growth and consequent saturation of themicroglial
cell density inside the aggregate (red solid line infigure 3(c)) as well as the shift of the point xmax, where the cell
density ismaximal, in the direction towards the electrode (red solid line infigure 3(b)). The abrupt shrinkage of
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the sheath at some threshold value of Jmay be caused by drastic changes in grad(x) (10),meaning the growth of
chemosensitivity with respect to ATP andADP. The latter effect resembles, to some extent, the enhancement of
the immune response, which is observed after the interaction ofmicroglia and laminin [48] and is caused by the
ATP-induced vesicle shedding and release of IL-1 cytokine bymicroglia [59]. In fact, the release of IL-1 cytokine
by themicroglia in response to themassive release of ATPmightmean the appearance of another substance,
playing the role of a chemo-attractant. It becomes clear in this context that the IL-1 ra electrode coating allows to
weaken that part of the chemotactic signaling process, which is related to theATP-induced release of IL-1
cytokine [59].
The application of the IL-1 ra coating causes qualitative changes in the tissue response to the growing level of
extracellular ATP. In particular, the presence of bioactive coatingweakens the additional chemo-attraction
induced by the released IL-1 cytokines and prevents the shrinkage of the insulating sheath (green curve in
figure 3(a)).Moreover, the presence of IL-1 ra induces strong reduction ofmicroglial cell density inside the
aggregate (green curve infigures 3(c)) and prevents itsmovement in the direction towards the electrode surface
even for high levels of ATP release (green curve infigures 3(b)). Another important parameter affecting the
process ofmicroglia chemotaxis is γ, which is responsible for the functional regulation of adenosine A3A/A2A
receptors. The substantial increase of themicroglia cell density is observed for rather large values of γ in the
absence of bioactive coating (see the red curve infigure 3(d)). This fact can be explained by the enhanced
retractions ofmicroglial cells which react this way to the increase of adenosine levels in the ECS. As shown in
figure 3(d), the presence of IL-1 ra compensates the growth of the cell density caused by the increased level of
extracellular adenosine. Dependences similar to those presented infigure 3 can be reproduced in awide range of
the values of parameters shown in table 1.
To study the role played by the parameters, characterizing the bioactive coating, on the aggregation process,
we calculated themicroglial cell density (13) for different values of the chemosensitivity coefficient χ4 aswell as
for the different values of IL-1 ra a concentrationsM0. As illustrated in figure 4, these two parameters have a
similar effect on the cell density, namely, both a substantial increase of chemotactic sensitivity to IL-1 ra (see
figure 4(a)) and a high concentration of IL-1 ra near the electrode surface lead to a strong reduction of the
aggregate and limit the spread of inflammatory factors.
Figure 3.The dependences of spatial locations of the globalminimum xb (a) andmaximum xmax (b) of the gradient (10) on the rate of
ATP release. The dependences of the absolutemaximal values of the cells density inside the aggregate on the amount of released ATP
(c) and on the parameter γ regulating the function of adenosine receptors (d). All dependences were calculated for the cases of the
absence (red curves) and presence (green curves) of the biologically active coating. The parameters values used in the calculations can
be found in table 1.
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4. Stability of homogeneous steady state and impact of bioactive coating
To study the impact of the bioactive coating in terms of stability theory, we linearized the equations (6) about the
homogeneous steady state n y y y y y( ˆ, ˆ , ˆ , ˆ , ˆ , ˆ )1 2 3 4 5 and reduced our stability analysis to the solution of eigenvalue
problem. For the one-dimensional spatial domain of length Lwith no-flux boundary conditions, the
eigenfunctions are of the formΦ =x j kx( ) exp ( )n , and the eigenvalues are π=k n Ln2 2 2 2, where π=k n L is the
wavenumber and the positive integer n is themode number. Let us consider small perturbations of the steady
state of the form:
λ= +( ) ( )n y y y y y x t n y y y y y t j kxˆ, ˆ , ˆ , ˆ , ˆ , ˆ ( , ) , , , , , exp ( ). (14)1 2 3 4 5 0 10 20 30 40 50
A substitution of the equations (14) into (6) and linearization of the obtained systemof equations allowed us to
get the Jacobianmatrix:
Table 1.Description and values of parameters used in simulations.
Parameter Description Value Reference
D1 Randommotility ofmicroglial cells 3
μm
min
2
[47]
D2,3,4,5,6 Diffusion coefficients for ATP, ADP, adenosine, IL-1 ra 100
μm
min
2
[47]
v1 Rate of ATP toADP conversion byATPase 17min
−1 [50]
v2 Rate of ADP toAMP conversion byADPase 10min
−1 [50]
w1 Rate of ATP toAMP conversion by cd39 0.16min
−1 [46]
v3 Rate of AMP to adenosine conversion by cd73 15min
−1 [50]
v4 Rate of adenosine uptake 2.36min
−1 [50]
χ1 Chemosensitivity ofmicroglia to ATP 6 μμ
m
M min
2
[47]
χ2 Chemosensitivity ofmicroglia to ADP 6 μμ
m
M min
2
[47]
χ3 Chemoattraction/chemorepulsion of adenosine 1 μμ
m
M min
2
[34]
a Rate of ATPproduction bymicroglial cells 10min−1 [50]
b Rate of ATP production by astrocytes 10min−1 [51]
k1 Reaction constant for ATPase 5 μM [57]
k2 Reaction constant for ADPase 1.5 μM [57]
k3 Reaction constant for cd73 1 μM [57]
k4 Reaction constant for adenosine degradation 0.22 μM [57]
k5 Reaction constant for cd39 0.22 μM [57]
ki Reaction constant for AMPdegradation 1.0 μM [57]
kb Reaction constant for ATP release 2.0 μM [57]
d Uptake rate constant for IL-1 ra 0.5min−1
q q,s satp adp Binding constants for ATP andADP 2.2min
−1
qsado Binding constant for adenosine 1.57min
−1
J0 Rate of ATP release near the electrode surface 100min
−1
L0 Rate of IL-1 ra emission near the electrode surface 1min
−1
M0 Concentration of IL-1 ra near the electrode surface 25min
−1
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Figure 4.The spatial dependences ofmicroglial cells’ density (13) calculated (a) for the different values of coefficient χ4 and (b) for the
different values of concentration of IL-1 ra on the electrode surfaceM0. The value of the coefficient χ =54 isfixed in (b).
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and the determinant λ − A k Idet( ( ) )2 to obtain the sixth-order characteristic equation:
λ λ λ λ λ λ+ + + + + + =( ) ( ) ( ) ( ) ( ) ( ) ( )a k a k a k a k a k a k a k 0, (15)1 2 6 2 2 5 3 2 4 4 2 3 5 2 2 6 2 7 2
whose roots λ1 .. 6 define the domain of spatial instability for the homogeneous steady state. The dependences
λ k( )1 .. 6 2 are calculated for a particular range of values of the control parameters (figure 4(a)). Obviously,five
eigenvalues take negative values for all wavenumbers. Thus, the spatial stability of the homogeneous steady state
depends on the sign of λ6 and is defined by the dispersion curve λ k( )6 2 as shown infigure 5(a). To reveal the
impact of the bioactive coating on the spatial stability of the homogeneous steady state, we calculated the
dispersion curves λ k( )6 2 for different values of the chemosensitivity χ4. As follows from the results presented in
figure 5(b), an increase of the chemosensitivity to the IL-1 ra leads to a substantial decrease of the area of
instability where λ6 takes positive values.Moreover, the analysis of the roots of the characteristic equation (15)
bymeans of the Routh–Hurwitz theory allowed us to estimate the boundaries of the domain of the spatial
instability. The results of this analysis are in good agreementwith the results of the direct numerical solution of
equation (15). As illustrated infigure 5(b), the area of instability isfinite, localized in space near the electrode and
decreases as the coefficient of chemosensitivity to the IL-1 ra χ4 increases. Also the absolute values of λ6 decrease
in the presence of the IL-1 antagonist, whatmay be interpreted as a reduction of the instability caused by the
0.05
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6 8
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0.01
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0.04
Figure 5. (a) The dispersion curves calculated from the (15) for the values of parameters presented in table 1 and χ =04 ; (b) the
dispersion curves λ k( )6 2 , calculated for the different values of χ4. The borders of the area of spatial instability (black solid line) were
calculated bymeans of the Routh–Hurwitz criterion.
Figure 6.The normalized two-dimensional spatial distributions ofmicroglial cell density calculated for themodel equations (5) in the
absence (a) and in the presence (b) of bioactive coating. The rate of ATP release is J=100 and γ = 0.15. The values of the other
parameters can be found in table 1. The size of the square domain around the electrode is ×10 10 in arbitrary units. The total time of
the numerical integration isT=100. The chosen spatial scale is Δ =x 0.033.
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release of ATP in ECS. These last findings are in good agreementwith the analytical results presented above
concerning the impact of the bioactive coating on the size and location of the glial sheath. Indeed, as seen from
the results presented above infigure 2(c), the use of the bioactive coating leads to a substantial decrease of the cell
density inside the aggregate as well as its removal from the electrode.
5. Results of numerical simulations
To verify the analytical results obtained for the original nonlinearmodel, we performed numerical integrations
of the dimensionless equations (5) for the two-dimensional case by using the standard finite-difference scheme
togetherwith the high order explicitmethod for stiff differential equations utilizing the explicit Runge–Kutta–
Chebyshev formulas [52]. The choice of the two-dimensional geometrymay simplify the comparison of the
obtained numerical results and results of representativemicroscopy (X10) data of horizontal brain sections
immunostained forGFAP surrounding the electrode insertion site, which are presented in [49].We assumed
that the electrode is located in the center of the square domainwhich allows us tomodel the realistic situation,
when it is symmetrically enwrapped by themicroglial cells. The obtained values of the cell density were
normalized by the total density inside the chosen domain, which is calculated as a sumof all values of n,
calculated in each point on the equidistant grid. Since the expressions forA1, A2, A3 are different for the systems
(5) and (6), then for the numerical integration of the system (5) the absolute values of chemosensitivity
coefficients were chosen equal to χ χ χ= × = × = ×− − −5 10 , 5 10 , 1 105 5 2 5 3 5, respectively.
As shown infigure 5, the emission of IL-1 ra proteins by the anti-inflammatory coating leads to a drastic
reduction of the cell density around the electrode and nearly prevents the scarring process. The two-dimensional
stationary spatial distributions of ATP, ADP and adenosine have similar profiles to those obtained in the one-
dimensional case shown in figure 2(b). These findings are in good qualitative agreementwith recent
experimental results [49]. In particular, the two-dimensional plots infigure 6 resemble the results of
representativemicroscopy (X10) data of horizontal brain sections, which can be found in [49]. As already
discussed in section 3, the strategy of the suppression of the acute immune response aims to eliminate the
chemotactic signalingwhich is related to the release of IL-1 cytokines andmay be considered as a very effective
approach to prevent scar formation.Moreover, the suppression of the cytokine releasemay play a crucial role in
the prevention of astrogliosis responsible for substantial decrease of the extracellular volume. The shrinkage of
extracellular volume is known to induce the appearance of diffusive barriers in the ECSwhich are able to affect
the diffusion ofmolecules and limit the spread of the chemotactic signaling to the closest proximity of the
electrode [60].
6. Conclusions
Wepresented a simplemathematicalmodel of the acute chemotactic response of themicroglia to the electrode
implantation, which is accompanied by amassive release of ATP.Given the recent experimental results, we
assumed that the chemotactic signaling andmotility ofmicroglia aremaintained by the chain of enzymes’
reactions on the surfaces ofmicroglial cells, which performs the hydrolysis of ATP to adenosine. Based on our
model, we found that the release of a substantial amount of ATP into the ECS induces the chemotacticmotion of
microglia towards the electrode. The stationary spatial distributions of ATP and its hydrolysis products together
with the stationary distribution ofmicroglial cell density were calculated analytically for the one-dimensional
case.We also demonstrated the possibility of an abrupt shrinkage of the insulating sheath for some threshold
values of ATP concentration.
With ourmodel, we analyzed possible effects of anti-inflammatory bioactive coating on the glial scarring
process. In particular, we found that a recently proposed bioactive coating shifts the emerging encapsulating
sheath away from the electrode, preventing its abrupt shrinkage and stabilizing the cell density around the
electrode at amoderate level. Thus, the usage of the anti-inflammatory bioactive coating containing the proteins
of the IL-1 antagonist, is able to suppress or significantly diminish the scarring process around the implantation
site which, in turn, can increase the conductance and signal-to-noise ratio of the electrode–tissue interface.
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